Anthem Biosciences is a FDA audited Contract Research and Innovation Service Provider (CRISP), with more than 1000 scientific staff in it’s two sites in Bengaluru, India. Since commencing operations in 2007, Anthem has become a one stop solution for the clients with a comprehensive portfolio of research services under GLP regulations at AAALAC-accredited preclinical test facility. Anthem specializes in multidisciplinary toxicity studies to evaluate the potential for toxicity of therapeutics, personal care products, nutraceuticals, agrochemicals, chemicals and medical devices with well-designed in vitro and in vivo toxicology studies following regulatory guidelines of global regulatory agencies (OECD, OPPTS, EPA, CIBRC, CIPAC, SENASA, SENAVE etc.).
Main markets: Europe, USA, China, Japan, Israel, India, South America, Latin America AGROCHEMICAL TOXICITY STUDIES
-Genetic toxicity / Mutagenicity
-Eco toxicity (alga, cyanobacteria, daphnia, fish, earthworm, honeybee, avian species)
-Acute 6 pack toxicity
-Sub-chronic and chronic toxicity
-Reproductive toxicity and teratology
-Physico-chemical properties (five batch analysis, analytical services, impurity profiling)
-Storage stability
-Method development and validation
-E-fate, ready biodegradability residue analysis (plant, soil, water)
-Test items for the studies: rat, mouse, rabbit, guinea pig, aquatic and terrestrial organisms & cell lines
Picture
Head, Pre-clinical research
Tel: +91 97412 23861
prasad.s@anthembio.com
VP-Sales and marketing, Pre-clinical services
Tel: +91 92435 55510
Satish.s@anthembio.com